Inhibition of glycogen synthase kinase-3beta promotes nuclear export of the androgen receptor through a CRM1-dependent mechanism in prostate cancer cell lines.
about
Stilbene induced inhibition of androgen receptor dimerization: implications for AR and ARΔLBD-signalling in human prostate cancer cellsThe Ddx5 and Ddx17 RNA helicases are cornerstones in the complex regulatory array of steroid hormone-signaling pathwaysGlycogen synthase kinase-3β is involved in ligand-dependent activation of transcription and cellular localization of the glucocorticoid receptor.Inhibition of glycogen synthase kinase-3β counteracts ligand-independent activity of the androgen receptor in castration resistant prostate cancer.A screen for transcription factor targets of glycogen synthase kinase-3 highlights an inverse correlation of NFκB and androgen receptor signaling in prostate cancerThe fibroblast growth factor 14·voltage-gated sodium channel complex is a new target of glycogen synthase kinase 3 (GSK3).Decreased store operated Ca2+ entry in dendritic cells isolated from mice expressing PKB/SGK-resistant GSK3.KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin [corrected] in prostate cancer models.IκB kinases modulate the activity of the androgen receptor in prostate carcinoma cell lines.Glycogen synthase kinase-3: a potential preventive target for prostate cancer managementModulation of glycogen synthase kinase-3β following TRAIL combinatorial treatment in cancer cells.Effects of sorafenib on C-terminally truncated androgen receptor variants in human prostate cancer cells.N-terminal domain of the androgen receptor contains a region that can promote cytoplasmic localization.Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer.
P2860
Q28539233-7B0B92F6-451F-4804-9C69-1DB773B35C3EQ28854594-0397FFAD-4C25-452B-B89F-1D419A606B21Q33636330-5290E667-ADEB-4018-B506-9B8D37094365Q34043113-172DE28B-C2F4-487B-957F-A3241D36286BQ34483490-A2317E24-05C4-418F-A88C-20E15A42137FQ34703974-30435A5D-40F5-487E-BF11-FDD97500D643Q35093703-3CC22C0A-13A1-4672-971A-E1B062BEC81BQ35856215-60B2D8FA-5FC6-4999-8059-AFE0C2DFFF2DQ35882191-F24FFB1E-CB75-4615-A3F9-F118E0D2956EQ36580561-8CDF9B39-0CD5-4CCA-B7CF-2C1BB8A6471AQ37687091-C5F80AD7-5F49-49F0-8444-E21ED233A0CEQ39251637-9C78E81F-E008-4B4D-9A2A-38A99479606BQ41899994-201EA350-8F77-4BA8-A28D-C6B260704482Q49164320-2CC550F8-B525-4E5F-B664-B03874EB27CC
P2860
Inhibition of glycogen synthase kinase-3beta promotes nuclear export of the androgen receptor through a CRM1-dependent mechanism in prostate cancer cell lines.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Inhibition of glycogen synthas ...... in prostate cancer cell lines.
@en
Inhibition of glycogen synthas ...... in prostate cancer cell lines.
@nl
type
label
Inhibition of glycogen synthas ...... in prostate cancer cell lines.
@en
Inhibition of glycogen synthas ...... in prostate cancer cell lines.
@nl
prefLabel
Inhibition of glycogen synthas ...... in prostate cancer cell lines.
@en
Inhibition of glycogen synthas ...... in prostate cancer cell lines.
@nl
P2093
P356
P1476
Inhibition of glycogen synthas ...... in prostate cancer cell lines.
@en
P2093
Ludwig Rinnab
Marcus V Cronauer
Stefanie V Schütz
P2860
P304
P356
10.1002/JCB.22500
P577
2010-04-01T00:00:00Z